Stay updated on Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4. This reflects an updated version of the study record, without altering the reported study details.
    Difference
    0.1%
    Check dated 2026-05-15T16:02:02.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page footer revision was updated from v3.5.2 to v3.5.3, indicating a minor site/version update without changing the study information presented.
    Difference
    0.1%
    Check dated 2026-04-24T05:49:24.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:04:25.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No visible changes to the study details or page functionality.
    Difference
    0.1%
    Check dated 2026-03-18T22:53:15.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision updated: v3.4.2 removed; v3.4.3 added.
    Difference
    0.1%
    Check dated 2026-03-11T20:20:49.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Added site revision tag Revision: v3.4.2 and removed an operating-status notice (lapse in government funding) along with Revision: v3.4.1. The core study details, eligibility criteria, and trial information remain unchanged.
    Difference
    0.5%
    Check dated 2026-02-11T05:32:36.000Z thumbnail image

Stay in the know with updates to Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.